Sensitivity of the Medication Possession Ratio to Modelling Decisions in Large Claims Databases.
Eberechukwu OnukwughaDavid CzerwinskiEberechukwu OnukwughaPublished in: PharmacoEconomics (2019)
Some of the decisions considered had a large impact on the MPR. Therefore, it is important for researchers to standardize approaches for study period length and overlapping prescription claims. We also conclude that transparent reporting of modelling decisions will facilitate the interpretation of results and comparisons across studies.